Lung Cancer

A colleague describes Dr. Edward S. Kim’s devotion to improving lung cancer care and creating more inclusive clinical trial practices.

Many individuals were affected by cancer in the year 2021, including those in the spotlight. Here’s a roundup of the most-read cancer-related news impacting celebrities this year.

A woman writes about the unique lung cancer advocate who leads his endeavors with his heart for change.

After receiving an advanced non-small cell lung cancer diagnosis, a competitive runner and cyclist began running toward a new goal: becoming a lung cancer advocate.

Ellen Petree worked with local health care leaders and community nurses to help reduce the number of children who went on to use tobacco, lowering their risk for lung cancer.

As treatments for NSCLC improve survival, this benefit may be affected by depression and anxiety, which is common in patients with the disease and may require patients to advocate for cognitive behavioral therapy among other approaches.

A man writes about his wife’s oncologist, Dr. Frederic J. Kaye, and describes how he went above and beyond to provide supportive care during her lung cancer journey.

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

A colleague describes Dr. Nagla Abdel Karim’s exemplary compassion for patients with lung cancer and how she works hard to increase representation in cancer clinical trials.

CURE® took a look back at our most-read lung cancer stories from this year.

A cancer survivor describes an inspiring close friend who has been dealing with cancer for 13 years and refuses to give up.

A woman explains how her close friend achieved remission from stage 4 lung cancer after being treated by Dr. Bret Friday – a superhero in her book.

From Kathy Griffin sharing that she is now cancer free to Michael Bublé discussing his son’s cancer journey, here’s what’s happening in the cancer landscape this week.

A lung cancer survivor explains how a serendipitous friendship with her stepson’s girlfriend’s aunt changed her life.

The first patient was randomized in the phase 2 trial examining Tedopi and Opdivo for non-small cell lung cancer.

A patient with lung cancer explains how Dusty Donaldson's work for patients and survivors has inspired and touched the lives of many people.

Dr. Roman Perez-Soler received his original training in Spain but has been a constant beloved presence in the U.S. lung cancer arena for more than 30 years.

Simply put, Jan Poulsen is an inspiration to those diagnosed with lung cancer, a friend writes.

Lilian is a gentle soul who was placed on Earth for this purpose: to guide those with the most common cancer there is.

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

A colleague explains how Jody Ruth Steinhardt helps guide patients through lung cancer screenings and offers them support.

A colleague describes how Suzanne Walker has touched the lives of many patients with lung cancer over the years.

An oncologist explains why Tami Tittlefitz, a lung cancer nurse practitioner, is "one of a kind: a saint and a healer."

A lung cancer survivor explains how Dr. Brendon Stiles is an asset to the lung cancer community. "He is such an accomplished thoracic surgeon, but he is so humble and generous with his time."

It is my hope that the cancer field continues to grow the novel therapy for not only patients with lung cancer, but well beyond. It is critical that the public be aware of how research and clinical trials are catalysts to better the outcomes of patients with cancer.

Targeted therapies offer new hope for patients with HER2-mutated non-small cell lung cancers.

A patient with stage 4 lung cancer explains why Dr. Shirish Gadgeel is a ray of sunshine and hope who makes patients with cancer feel that living a long life is a possibility.

Christine Eastep demonstrates the highest commitment to every one of the patients and her staff to improve the outcomes in lung cancer treatment, with a commitment to sending her staff nurses to tobacco cessation classes.

Dr. Roy H. Decker is a lung cancer hero — a “triple threat” in lung radiation oncology as a clinical innovator, teacher and ground-breaking clinical trialist, explains a colleague.

Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.